What is the Medplus Health Services PE ratio today?
Medplus Health Services' PE ratio is 33.9 at the previous close (₹595.00 a share): a market capitalisation of ₹7,148 crore divided by consolidated net profit of ₹211 crore over the last four quarters (Q3 FY26 to Q2 FY27). On FY26 net profit (₹220 crore) it is 32.5.
What is the Medplus Health Services net worth?
Medplus Health Services' net worth — shareholders' equity in its consolidated balance sheet — was ₹2,068 crore on 30 September 2026, up 12.1% from ₹1,845 crore a year earlier. Its market value is a different figure: a market capitalisation of ₹7,148 crore at the previous close.
What is the Medplus Health Services book value per share?
Medplus Health Services' book value per share was ₹172.16 on 30 September 2026: shareholders' equity of ₹2,068 crore divided by the 12.01 crore shares in issue, up 11.8% from ₹153.98 a year earlier. The share price at the previous close was ₹595.00.
What is the Medplus Health Services PB ratio (price to book value)?
Medplus Health Services' price-to-book (PB) ratio is 3.46 at the previous close: a market capitalisation of ₹7,148 crore divided by shareholders' equity (book value) of ₹2,068 crore on 30 September 2026. That is a book value of ₹172.16 per share against a share price of ₹595.00.
What is the Medplus Health Services ROE and ROCE?
In FY26, Medplus Health Services' return on equity (ROE) was 11.8% and its return on capital employed (ROCE) was 10.8%. ROE is net profit divided by average shareholders' equity (the start and end of the year); ROCE is operating profit (EBIT) divided by average capital employed (total assets less current liabilities). In FY25, ROE was 9.1% and ROCE 9.0%.
What is the Medplus Health Services free cash flow?
In FY26, Medplus Health Services generated ₹496 crore of cash from operations and spent ₹123 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of ₹373 crore. In FY25 it was ₹481 crore.
What is the Medplus Health Services market cap?
Medplus Health Services' market capitalisation was ₹7,148 crore at the previous close: 12.01 crore shares at ₹595.00 each.
Is Medplus Health Services debt free?
Yes. Medplus Health Services had no borrowings on 30 September 2026 (consolidated balance sheet), and it held ₹363 crore of cash, bank balances and current investments.
What is the Medplus Health Services EPS?
Medplus Health Services' basic earnings per share (EPS) were ₹18.33 in FY26, against ₹12.57 in FY25. Over the last four quarters (Q3 FY26 to Q2 FY27) they add up to ₹17.64.
What is the Medplus Health Services debt to equity ratio?
Medplus Health Services' debt-to-equity ratio was 0.00 on 30 September 2026: no borrowings against total equity of ₹2,068 crore. A year earlier, on 30 September 2025, it was 0.00.
What is the Medplus Health Services promoter holding?
Promoters held 40.19% of Medplus Health Services on 30 September 2026, unchanged from the previous quarter and down 0.10 percentage points from 40.29% a year earlier, according to the shareholding pattern filed with NSE.
What are the Medplus Health Services latest quarterly results?
Medplus Health Services' latest results are for Q2 FY27 (July–September 2026): consolidated net profit ₹56.1 crore, up 1.0% from ₹55.5 crore in Q2 FY26; revenue from operations ₹2,037 crore, up 21.3% year on year.
What is the Medplus Health Services shareholding pattern?
On 30 September 2026, Medplus Health Services' shares were held by promoters 40.19%, foreign portfolio investors (FII/FPI) 12.58%, domestic institutions (DII) 31.89% (including mutual funds at 27.39%) and retail and other non-institutional investors 15.29%. Over the year, FII holding was down 3.96 percentage points from 16.54% and DII holding was up 5.37 percentage points from 26.52%.
How does Medplus Health Services compare with its peers?
On FY26 consolidated figures, against Apollo Hospitals Enterprise and MSTC: Medplus Health Services' operating margin of 4.7% is the lowest of the three (Apollo Hospitals Enterprise 11.5%, MSTC 57.8%; peer average 34.6%); its return on equity of 11.8% is the lowest of the three (Apollo Hospitals Enterprise 22.0%, MSTC 26.6%; peer average 24.3%); its revenue growth over three years of 14.8% a year is the second highest of the three (Apollo Hospitals Enterprise 14.9% a year, MSTC −20.0% a year; peer average −2.5% a year).
Medplus Health Services vs Apollo Hospitals Enterprise: how do they compare?
In FY26, Medplus Health Services earned net profit of ₹220 crore on revenue of ₹6,892 crore, against ₹1,942 crore on ₹25,229 crore for Apollo Hospitals Enterprise. Medplus Health Services' operating margin was 4.7% (Apollo Hospitals Enterprise 11.5%) and its return on equity 11.8% (Apollo Hospitals Enterprise 22.0%).
What is the Medplus Health Services revenue and profit in FY26?
In FY26 (April 2025–March 2026), Medplus Health Services' consolidated net profit was ₹220 crore, up 46.1% from ₹150 crore in FY25, on revenue from operations of ₹6,892 crore (up 12.3%). Over three years, from FY23, net profit was up 341.4%.
When are the Medplus Health Services next results?
Medplus Health Services has reported Q2 FY27. Its next results, for Q3 FY27 (October–December 2026), are due by 14 February 2027 under SEBI's 45-day rule; the company notifies the board-meeting date at least two working days before.
Consolidated figures from the company's filings with NSE; prices are NSE closing prices.
